Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin by Oser, Matthew G, MD, Niederst, Matthew J, PhD, Sequist, Lecia V, MD, Engelman, Jeffrey A, Dr

Get full text

Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study by Camidge, D Ross, Dr, Bang, Yung-Jue, Prof, Kwak, Eunice L, MD, Iafrate, A John, MD, Varella-Garcia, Marileila, Prof, Fox, Stephen B, Prof, Riely, Gregory J, MD, Solomon, Benjamin, MBBS, Ou, Sai-Hong I, MD, Kim, Dong-Wan, Prof, Salgia, Ravi, Prof, Fidias, Panagiotis, MD, Engelman, Jeffrey A, MD, Gandhi, Leena, MD, Jänne, Pasi A, MD, Costa, Daniel B, MD, Shapiro, Geoffrey I, MD, LoRusso, Patricia, DO, Ruffner, Katherine, MD, Stephenson, Patricia, ScD, Tang, Yiyun, PhD, Wilner, Keith, PhD, Clark, Jeffrey W, MD, Shaw, Alice T, MD

Get full text

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis by Shaw, Alice T, Dr, Yeap, Beow Y, ScD, Solomon, Benjamin J, MD, Riely, Gregory J, MD, Gainor, Justin, MD, Engelman, Jeffrey A, MD, Shapiro, Geoffrey I, MD, Costa, Daniel B, MD, Ou, Sai-Hong I, MD, Butaney, Mohit, BS, Salgia, Ravi, Prof, Maki, Robert G, MD, Varella-Garcia, Marileila, Prof, Doebele, Robert C, MD, Bang, Yung-Jue, Prof, Kulig, Kimary, PhD, Selaru, Paulina, MSPH, Tang, Yiyun, PhD, Wilner, Keith D, PhD, Kwak, Eunice L, MD, Clark, Jeffrey W, MD, Iafrate, A John, MD, Camidge, D Ross, MD

Get full text